Top rated alzheimer's disease clinical trials in High Point, North Carolina
Here are the top 10 medical studies for alzheimer's disease in High Point, North Carolina
Popular filter options for alzheimer's-disease high-point trials
Phase 3 Clinical Trials
View 35 phase 3 medical studies.
Simufilam for Alzheimer's Disease
Recruiting1 awardPhase 3
Greensboro, North Carolina
This trial will study the safety and effectiveness of simufilam, a drug for Alzheimer's disease, for one year. 750 people with mild-to-moderate Alzheimer's will be given the drug or a placebo twice daily. The trial will assess cognitive enhancement and functional decline.
View More Alzheimer's-disease High-point Trials
See another 18 medical studies focused on alzheimer's-disease high-point.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.